
July 15, 2005 -- The FDA today has issued a health advisory regarding the safe use of fentanyl skin patches (brand name Duragesic) in response to reports of deaths in patients using this potent narcotic medication for pain management.
The FDA is conducting an investigation into the deaths associated with these patches. It's unclear if the deaths are due to inappropriate use of the patch or factors related to the quality of the product, according to the advisory.
Deaths and overdoses have occurred in patients using both the brand name product Duragesic and the generic product fentanyl. The directions for using the fentanyl skin patch must be followed exactly to prevent death or other serious side effects from overdosing with fentanyl, according to the FDA.
Some patients and doctors may not be fully aware of the dangers of this very strong narcotic painkiller. Therefore, the FDA is highlighting the following important safety information:
Patients who use the fentanyl skin patch should be aware of the signs of fentanyl overdose: trouble breathing or shallow breathing; tiredness, extreme sleepiness, or sedation; inability to think, talk, or walk normally; and feeling faint, dizzy, or confused. If these signs occur, patients or their caregivers should get medical attention right away.
A patient using the fentanyl skin patch may have a sudden and possible dangerous rise in their body level of fentanyl or have a stronger effect from fentanyl if they:
Patients should discuss all the above factors with their doctor or pharmacist.